Sulfonylamide compounds as CDK2 inhibitors
US11919904B2 · kind B2 · utility
1Cited by
27References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2020 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | Mar 14, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2440/14
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present application provides sulfonyl amide compounds, which are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.